Prostate Cancer - Results from #27740

Chemotherapy for urological cancer : Usefulness and feasibility of current protocols - Abstract June 8, 2011

Strategies for reducing cancer incidence and mortality in African American and Arab American and Chaldean Communities in the Detroit Metropolitan area - Abstract June 8, 2011

A decade in prostate cancer: From NMR to metabolomics - Abstract June 8, 2011

The role of inflammation and infection in prostate cancer: Importance in prevention, diagnosis and treatment - Abstract June 8, 2011

Incidental prostate cancer revisited: Early outcomes after holmium laser enucleation of the prostate - Abstract June 8, 2011

New therapies for castration-resistant prostate cancer: Efficacy and safety - Abstract June 8, 2011

Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells - Abstract June 8, 2011

Prognostic significance of neuroendocrine differentiation in patients with Gleason score 8-10 prostate cancer treated with primary radiotherapy - Abstract June 8, 2011

Editor's Commentary - Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells June 8, 2011

Drug shows promise in prostate cancer spread to bone June 8, 2011

CTC prognostic for overall survival in prostate cancer trial June 8, 2011

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression - Abstract June 8, 2011

The feasibility of endorectal MR elastography for prostate cancer localization - Abstract June 7, 2011

Prostate I 125 Brachytherapy: Critical evaluation of mid term oncologic and functional results after 250 cases - Abstract June 7, 2011

Incontinence after radical prostatectomy: A patient centered analysis and implications for preoperative counseling - Abstract June 7, 2011

New strategies for medical management of castration-resistant prostate cancer - Abstract June 7, 2011

Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population - Abstract June 7, 2011

Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer - Abstract June 7, 2011

Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer - Abstract June 7, 2011

Zoledronic acid to prevent bone loss in Chinese men receiving androgen deprivation therapy for prostate cancer - Abstract June 7, 2011

Page 1388 of 1435